European Journal of Cardiovascular Medicine

Medicines constitute one of the most important therapeutic interventions in modern healthcare. Appropriate prescribing and proper medication use are essential for achieving desired clinical outcomes. However, irrational prescribing practices, medication errors, poor adherence, and drug-related problems continue to pose significant challenges worldwide.

The World Health Organization (WHO) defines rational use of medicines as patients receiving medications appropriate to their clinical needs, in doses that meet individual requirements, for an adequate period, and at the lowest cost. Despite advancements in healthcare, studies indicate that nearly half of all medicines are prescribed or used inappropriately.

Hospitalized patients are particularly vulnerable to medication-related complications due to multiple diseases, extensive medication use, and frequent therapeutic modifications. Drug-related problems may arise at any stage of medication management, including prescribing, dispensing, administration, monitoring, and patient compliance.

An integrated medical and pharmaceutical approach involving physicians, pharmacists, nurses, and patients is increasingly recognized as an effective strategy for improving medication safety and treatment outcomes.

Prescription Patterns in Hospitalized Patients

Prescription pattern analysis evaluates prescribing practices and promotes rational drug use. WHO prescribing indicators are commonly used to assess the quality of prescribing.

Common Findings in Hospital-Based Prescription Studies

1. High prevalence of polypharmacy.
2. Extensive use of antibiotics and injectable medications.
3. Variable rates of generic prescribing.
4. Incomplete adherence to essential medicine lists.
5. Increased risk of drug-drug interactions.

Studies conducted in tertiary care hospitals have reported an average of 4–8 drugs per prescription, with antibiotics, cardiovascular drugs, antidiabetics, analgesics, and gastrointestinal medications being the most frequently prescribed classes.

Factors Influencing Prescription Patterns

• Age and comorbidities
• Disease severity
• Physician prescribing behavior
• Hospital formulary restrictions
• Availability of medicines
• Clinical guidelines

Regular prescription audits are essential for identifying irrational prescribing trends and promoting evidence-based therapy.

Medication Adherence

Medication adherence refers to the extent to which a patient's medication-taking behavior corresponds with agreed recommendations from healthcare providers.

Types of Non-Adherence

Intentional Non-Adherence

• Fear of adverse effects
• Cost concerns
• Lack of perceived benefit

Unintentional Non-Adherence

• Forgetfulness
• Cognitive impairment
• Complex treatment regimens

Determinants of Medication Adherence

Patient Factors

• Age
• Education
• Health literacy
• Psychological status

Therapy Factors

• Polypharmacy
• Duration of treatment
• Adverse effects

Healthcare System Factors

• Accessibility of healthcare services
• Quality of patient counseling
• Physician-patient communication

Impact of Non-Adherence

Poor adherence may result in:

• Treatment failure
• Disease progression
• Increased hospital readmissions
• Higher healthcare expenditure
• Increased morbidity and mortality

Studies indicate that medication non-adherence affects approximately 30–50% of patients with chronic diseases worldwide.

Drug-Related Problems (DRPs)

Drug-related problems are events or circumstances involving drug therapy that interfere with desired health outcomes.

Classification of DRPs

1. Untreated indications
2. Improper drug selection
3. Subtherapeutic dosage
4. Overdosage
5. Adverse drug reactions
6. Drug interactions
7. Medication errors
8. Non-adherence

Prevalence of DRPs in Hospitalized Patients

Hospitalized patients frequently experience DRPs because of:

• Polypharmacy
• Multiple comorbidities
• Organ dysfunction
• Frequent medication changes

Commonly reported DRPs include adverse drug reactions, drug-drug interactions, inappropriate dosing, and medication omissions.

Risk Factors for DRPs

• Elderly age
• Polypharmacy (>5 medications)
• Renal impairment
• Hepatic dysfunction
• Prolonged hospital stay
• Multiple prescribers

Role of Clinical Pharmacists

Clinical pharmacists have emerged as key members of multidisciplinary healthcare teams.

Major Contributions

Medication Review

Identification of inappropriate medications and interactions.

Medication Reconciliation

Ensuring continuity of therapy during transitions of care.

Patient Counseling

Improving medication understanding and adherence.

Adverse Drug Reaction Monitoring

Early identification and reporting of adverse events.

Therapeutic Drug Monitoring

Optimizing drug dosing and minimizing toxicity.

Several studies have demonstrated that pharmacist-led interventions significantly reduce medication errors and improve clinical outcomes.

Integrated Medical and Pharmaceutical Approach

An integrated healthcare model promotes collaboration among physicians, pharmacists, nurses, and patients.

Core Components

1. Rational prescribing practices.
2. Evidence-based clinical guidelines.
3. Medication adherence monitoring.
4. Regular medication reviews.
5. Pharmacovigilance programs.
6. Patient education initiatives.
7. Electronic prescribing systems.

Benefits

• Reduced medication errors.
• Improved therapeutic outcomes.
• Enhanced patient satisfaction.
• Lower healthcare costs.
• Improved patient safety.

Challenges

Despite improvements, several barriers remain:

• Shortage of clinical pharmacists.
• Limited patient awareness.
• Inadequate pharmacovigilance systems.
• High prevalence of polypharmacy.
• Poor documentation practices.
• Resource constraints in developing countries.

Future Perspectives

Future strategies should focus on:

• Expansion of clinical pharmacy services.
• Implementation of electronic prescribing systems.
• Artificial intelligence-assisted medication review.
• Personalized medicine approaches.
• Strengthening medication adherence programs.
• Continuous professional education.

Prescription pattern evaluation, medication adherence assessment, and identification of drug-related problems are essential for optimizing pharmacotherapy in hospitalized patients. Irrational prescribing, poor adherence, and DRPs remain significant contributors to adverse patient outcomes. An integrated medical and pharmaceutical approach involving multidisciplinary collaboration can substantially improve medication safety, treatment effectiveness, and healthcare quality. Clinical pharmacists play a pivotal role in ensuring rational drug use and minimizing medication-related complications. Regular prescription audits, adherence monitoring, and comprehensive pharmaceutical care should become standard practices in hospital settings.

1. World Health Organization. How to Investigate Drug Use in Health Facilities: Selected Drug Use Indicators. Geneva: WHO; 1993.
2. World Health Organization. Promoting Rational Use of Medicines: Core Components. Geneva: WHO; 2002.
3. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497.
4. Sabaté E. Adherence to Long-Term Therapies: Evidence for Action. Geneva: WHO; 2003.
5. Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304–314.
6. Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med J. 2011;26(3):155–159.
7. Pathak A, Gupta VK, Maurya A, et al. Assessment of drug prescribing pattern using WHO indicators in hospitalized patients at a tertiary care teaching hospital in rural area of India. Int J Basic Clin Pharmacol. 2016;5(3):651–655.
8. Desai A, Mahajan N, Sewlikar S, Pillai R. Medication adherence: the critical step towards better patient outcome. Int J Basic Clin Pharmacol. 2017;6(2):328–332.
9. Suggett E, Marriott J. Risk factors associated with the requirement for pharmaceutical intervention in the hospital setting: a systematic review. Drugs Real World Outcomes. 2016;3(3):241–263.
10. Assiri GA, Shebl NA, Mahmoud MA, et al. What is the epidemiology of medication errors and error-related adverse events in adults managed in community care contexts? BMJ Open. 2018;8:e019101.
11. Alqenae FA, Steinke D, Keers RN. Prevalence and nature of medication errors and medication-related harm following discharge from hospital to community settings: a systematic review. Drug Saf. 2020;43(6):517–537.
12. Mathew AC, Aneesa MV, Rehman A, et al. Assessment of medication adherence patterns and various causes of non-adherence in long term therapies in a tertiary care hospital. Res J Pharm Technol. 2020;13(5):2447–2453.
13. Augustine DV, Nambiar DP, Saseendran M, et al. A review on drug related problems in a tertiary care teaching hospital, India. Int J Res Rev. 2020;7(5):270–276.
14. Mekonnen AB, McLachlan AJ, Brien JE. Pharmacy-led medication reconciliation programmes at hospital transitions: a systematic review. BMJ Open. 2016;6:e010003.
15. Ahmed Z, Saada M, Jones AM, Al-Hamid A. Assessment of medication errors and adherence to WHO prescription writing guidelines in a tertiary care hospital. Future J Pharm Sci. 2017;3(1):60–64.
16. Ayalew MB, Tegegn HG, Abdela OA. Drug related hospital admissions: a systematic review of recent literature. Bull Emerg Trauma. 2019;7(4):339–346.